| Dataset | NIBR DRUG-seq U2OS MoA Box Gene Expression Profiles |
| Category | transcriptomics |
| Type | drug perturbation |
| Description | Dose=10uM, N-(4-((4-(Cyclopentanecarbonyl)piperazin-1-yl)sulfonyl)phenyl)acrylamide, Tissue transglutaminase inhibitor targeting TGM2 (Novartis, 52938669) |
| External Link | https://pubchem.ncbi.nlm.nih.gov/compound/52938669 |
| Similar Terms | |
| Downloads & Tools |
3 genes differentially expressed following the AF-19-OG56_10uM drug perturbation from the NIBR DRUG-seq U2OS MoA Box dataset.
| Symbol | Name | Standardized Value |
|---|---|---|
| FTL | ferritin, light polypeptide | 0.608799 |
| NQO1 | NAD(P)H dehydrogenase, quinone 1 | 0.33386 |
| Symbol | Name | Standardized Value |
|---|---|---|
| MCAM | melanoma cell adhesion molecule | -0.20545 |